Sept 12 (Askume) – Stories on Roche receiving FDA approval for an injectable version of its multiple sclerosis therapy are incorrect and are withdrawn. There will be no replacement story.

    Categorized in:

    business, healthcare-pharmaceuticals,

    Last Update: September 13, 2024

    Tagged in:

    , , ,